SCHEMBL29960430

SCHEMBL29960430

CC(C)(CO)c1cc(Cl)ccc1Br

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ DDR1 Q08345 1/20 0.36
▸ MAPK14 Q16539 1/20 0.35
▸ TMPRSS4 Q9NRS4 1/20 0.34
▸ GAA P10253 3/20 0.33
▸ ALDH1A1 P00352 3/20 0.33
▸ HTT P42858 3/20 0.33
▸ RAD52 P43351 1/20 0.33
▸ MAPK1 P28482 5/20 0.33
▸ KDM4E B2RXH2 2/20 0.33
▸ MEN1 O00255 3/20 0.32
▸ KMT2A Q03164 3/20 0.32
▸ LMNA P02545 4/20 0.32
▸ NPSR1 Q6W5P4 1/20 0.32
▸ SMN1; SMN2 Q16637 3/20 0.32
▸ TSHR P16473 3/20 0.32
▸ CYP3A4 P08684 1/20 0.31
▸ TDP1 Q9NUW8 1/20 0.31
▸ NPC1 O15118 1/20 0.31
▸ HPGD P15428 1/20 0.31
▸ RAB9A P51151 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24398872 0.79 CYP3A4 (0.41) MAPK14GAAALDH1A1HTTMAPK1
SCHEMBL24730488 0.79 PGR (0.41) DDR1TMPRSS4GAAALDH1A1HTT
SCHEMBL15143953 0.78 MAPK1 (0.38) DDR1TMPRSS4GAAALDH1A1HTT
SCHEMBL16271595 0.75 SLC6A2 (0.36) DDR1TMPRSS4ALDH1A1HTTMAPK1
SCHEMBL12317693 0.72 CA2 (0.37) MAPK14ALDH1A1MAPK1SMN1; SMN2TSHR
SCHEMBL27334948 0.71 DDR1 (0.40) DDR1TMPRSS4GAAALDH1A1MAPK1
SCHEMBL30606438 0.70 KMT2A (0.46) ALDH1A1MEN1KMT2ATSHRCYP3A4
SCHEMBL1410268 0.70 TMPRSS4 (0.51) DDR1TMPRSS4HTTMAPK1KDM4E
SCHEMBL31193921 0.70 TMPRSS4 (0.51) DDR1TMPRSS4HTTMAPK1KDM4E
SCHEMBL30298217 0.69 KDM4E (0.40) DDR1TMPRSS4GAAALDH1A1HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022204150-A1 COMPOUNDS AND COMPOSITIONS FOR TREATING CNS DISORDERS BLUE OAK PHARMACEUTICALS, INC. (US) 2022-09-29 — — WO disclosed
Send feedback